Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
82 hedge funds and large institutions have $62.8M invested in Enzo Biochem, Inc. in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 14 closing their positions.
5% more capital invested
Capital invested by funds: $59.9M → $62.8M (+$2.86M)
5% less funds holding
Funds holding: 86 → 82 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
30% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 27
58% less call options, than puts
Call options by funds: $65K | Put options by funds: $153K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$2.39M |
| 2 |
LSVM
Lone Star Value Management
Old Greenwich,
Connecticut
|
+$2.21M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.05M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$467K |
| 5 |
CCM
Coe Capital Management
Highland Park,
Illinois
|
+$385K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.45M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$981K |
| 3 |
ClearBridge Investments
New York
|
-$922K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$844K |
| 5 |
Millennium Management
New York
|
-$731K |
ENZ Hedge Fund Activity: Q3 2015 in Review
82 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2015, worth a combined $62.8M — up 4.8% from $59.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ENZ and 10 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 19 added.
The largest buyer was First Light Asset Management, adding an estimated $2.39M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $1.45M sold.
- 82 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2015, down from 86 in Q2 2015.
- Funds reported $62.8M of Enzo Biochem, Inc. stock for Q3 2015, up 4.8% quarter-over-quarter.
- 10 funds opened new Enzo Biochem, Inc. positions in Q3 2015 and 14 closed out, a net change of -4 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2015 was First Light Asset Management, an estimated $2.39M added.
- The largest Enzo Biochem, Inc. seller in Q3 2015 was Kennedy Capital Management, an estimated $1.45M sold.
Based on aggregated 13F filings for Q3 2015.